trending Market Intelligence /marketintelligence/en/news-insights/trending/ovg3sg_uTwiArbFDvCEavg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

US FDA clears IRadimed's MRI-compatible IV infusion pump

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


US FDA clears IRadimed's MRI-compatible IV infusion pump

IRadimed Corp. received the U.S. FDA's 510(k) clearance for its MRidium 3860+ MRI-compatible IV infusion pump system, including its dose error reduction system software feature.

The system provides fluid delivery before, during and after an MRI scan. The dose error reduction system software allows users to create a unique drug library and set nominal values and limits for dose and concentration for specified infusion protocols.